Rhenovia Pharma, biotechnology company that specializes in applying biosimulation in researching and developing new therapies, has secured $738,000 or €540,000 for its second financing round.
SODIV fund
Breaking News
Rhenovia Pharma, biotechnology company that specializes in applying biosimulation in researching and developing new therapies, has secured $738,000 or €540,000 for its second financing round.
